Introduction
Glaucoma is a group of diseases that cause structural damage and visual field dysfunction, leading to progressive and irreversible vision loss.1 It is the second leading cause of blindness globally, accounting for 8% of blindness.2 Open angle glaucoma is the predominant type in people of African descent, in whom it has an earlier onset and more aggressive progression.1 3
In Nigeria, the prevalence is 5.02% (95% CI 4.60% to 5.47%) in people aged 40 years and older, with open-angle glaucoma and angle closure glaucoma comprising 86% and 14% of cases, respectively.4 Secondary glaucoma accounts for 8% of cases.4
Open-angle glaucoma usually runs a symptomless but progressive course, affecting the peripheral vision first. Therefore, many affected remain undiagnosed, presenting only when the disease has progressed significantly to affect the central vision late in the disease process. Late presentation is therefore an important setback in glaucoma management.5–7 In a review of population-based studies by Quigley and Broman,8 the global rate of previous diagnosis of open-angle glaucoma was low at 26%, and even lower at 8% for developing countries. In Nigeria, the rate was 5.6%,4 and more than half of patients are blind in one or both eyes at presentation.5 9 10 Late presentation has been attributed to low level of awareness about glaucoma, especially in developing countries.7 11–14 Creating awareness about the disease, its insidious nature and the importance of early detection and treatment in preventing blindness is therefore key in glaucoma control.
There is currently no consensus on a precise and easily implemented screening test or strategy for glaucoma detection.15 Population screening has not been found to be cost-effective,16 and opportunistic case finding may miss a majority of those with glaucoma.17 Screening targeted at high-risk groups such as blacks and people with a positive family history in first degree relatives16 and incorporation of glaucoma screening into other eye screening programmes such as cataract screening programmes have been suggested as more feasible control strategies.18 19
A study in Ibadan, Nigeria, that evaluated the effectiveness of screening programmes in early detection of glaucoma18 revealed that patients referred from outreach screening programmes were more likely to present with mild to moderate diseases than their counterparts referred from other sources. Such screening programmes may therefore be invaluable in early detection of glaucoma and may serve as feasible means of improving public awareness of the condition. Evidence necessary for planning can also be generated by examining the demographic features and visual characteristics of patients attending such outreach programmes.
The aim of this study was to determine the level of awareness and knowledge of glaucoma and the proportion of people with glaucoma among participants of a glaucoma urban outreach exercise. To the best of our knowledge, this is the first report of such a study carried out on an urban outreach population in Southeast Nigeria. Igbos, the predominant ethnic group in this region, as well as urban dwellers, have the highest prevalence of glaucoma in the country.4 The findings provide important evidence for efficient planning of comprehensive glaucoma management in the region.